Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online April 27, 2007
Diabetes Care 30:1813-1818, 2007
DOI: 10.2337/dc06-2630
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc06-2630v1
30/7/1813    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crutchlow, M. F.
Right arrow Articles by Townsend, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crutchlow, M. F.
Right arrow Articles by Townsend, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Validation of Steady-State Insulin Sensitivity Indices in Chronic Kidney Disease

Michael F. Crutchlow, MD1, Bruce Robinson, MD2, Binu Pappachen, MD2, Neil Wimmer, MD2, Andrew J. Cucchiara, PHD3, Debbie Cohen, MD2 and Raymond Townsend, MD2

1 Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania
2 Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
3 University of Pennsylvania General Clinical Research Center, Philadelphia, Pennsylvania

Address correspondence and reprint requests to Michael Crutchlow, MD, Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, Room 778, Clinical Research Building, 415 Curie Blvd., Philadelphia, PA 19104. E-mail: mcrutchl{at}mail.med.upenn.edu

OBJECTIVE— Insulin resistance may contribute to cardiovascular disease and the progression of renal insufficiency in patients with chronic kidney disease (CKD). However, feasible methods for estimating insulin sensitivity in large-population CKD studies have not been validated. The purpose of this study was to attempt to validate several commonly used steady-state insulin sensitivity (SI-SS) indices in a CKD population.

RESEARCH DESIGN AND METHODS— Twenty-seven subjects with estimated glomerular filtration rate (eGFR) ranging from 70 to <10 ml/min per 1.73m2 (median eGFR = 48) underwent a frequently sampled intravenous glucose tolerance test (FSIVGTT) on a single occasion. Correlations were obtained between the minimal model-derived insulin sensitivity parameter from the FSIVGTT (SI-FSIVGTT) and seven SI-SS indices derived from fasting insulin and glucose data obtained just before the FSIVGTT.

RESULTS— Each of the seven steady-state indices was significantly correlated with SI-FSIVGTT. For indices obtained using the mean of four fasting insulin and glucose values over 15 min, Pearson correlation coefficients (|r|) ranged from 0.51 to 0.87 (P < 0.01 for each). For indices using single fasting insulin and glucose values, |r| ranged from 0.51 to 0.72 (P < 0.01 for each). By both the four and one time point approaches, 1/I0 had the highest correlation with SI-FSIVGTT. The correlation with SI-FSIVGTT did not change significantly according to eGFR level for any of the SI-SS indices.

CONCLUSIONS— SI-SS indices are valid surrogates for SI-FSIVGTT in the CKD population. Their use will expand the range of testable hypotheses in CKD cohort studies.

Abbreviations: CKD, chronic kidney disease • CVD, cardiovascular disease • eGFR, estimated glomerular filtration rate • FSIVGTT, frequently sampled intravenous glucose tolerance test • HOMA, homeostasis model assessment • IR-HOMA, homeostasis model assessment of insulin resistance • SI-clamp, insulin sensitivity estimation from hyperinsulinemic-euglycemic clamp • SI-FSIVGTT, insulin sensitivity estimation from FSIVGTT • SI-SS, steady-state insulin sensitivity


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. Axelsson
The emerging biology of adipose tissue in chronic kidney disease: from fat to facts
Nephrol. Dial. Transplant., July 16, 2008; (2008) gfn376v1.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.